4-aminoquinoline has been researched along with Porphyria Cutanea Tarda in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, KE; Kuo, YF; Rizwan, M; Salameh, H; Sarairah, H; Singal, AK | 1 |
Singal, AK | 1 |
2 review(s) available for 4-aminoquinoline and Porphyria Cutanea Tarda
Article | Year |
---|---|
Relapse of porphyria cutanea tarda after treatment with phlebotomy or 4-aminoquinoline antimalarials: a meta-analysis.
Topics: Aminoquinolines; Antimalarials; Dose-Response Relationship, Drug; Humans; Phlebotomy; Porphyria Cutanea Tarda; Recurrence; Treatment Outcome | 2018 |
Porphyria cutanea tarda: Recent update.
Topics: Aminoquinolines; Animals; Carcinoma, Hepatocellular; Genetic Predisposition to Disease; Humans; Liver; Liver Neoplasms; Mice; Mutation; Neoplasm Recurrence, Local; Observational Studies as Topic; Phlebotomy; Porphyria Cutanea Tarda; Recurrence; Risk Factors; Uroporphyrinogen Decarboxylase | 2019 |